Naturally occurring and disease-associated auto-antibodies against topoisomerase I: A fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus

International Immunology

Volumn 21, Issue 4, 2009, Pages 415-422

  Simon, Diána ^a   Czömpöly, Tamás ^a   Berki, Timea ^a   Minier, Tünde ^a   Peti, Attila ^a   Tóth, Eszter ^a   Czirják, László ^a   Németh, Péter ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Naturally occurring auto antibodies; Phage display; Systemic lupus erythematosus; Systemic sclerosis; Topoisomerase I

Indexed keywords

AUTOANTIBODY; DNA TOPOISOMERASE; EPITOPE; HYBRID PROTEIN; IMMUNOGLOBULIN G; MALTOSE BINDING PROTEIN;

ADULT; AGE; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; WESTERN BLOTTING;

ADULT; AGED; AUTOANTIBODIES; DNA TOPOISOMERASES, TYPE I; EPITOPE MAPPING; EPITOPES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; RECOMBINANT FUSION PROTEINS; SCLERODERMA, SYSTEMIC;

EID: 63649150485     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp008     Document Type: Article

References (30)

1. Varga, J. and Abraham, D. 2007. Systemic sclerosis: A prototypic multisystem fibrotic disorder. J. Clin. Invest. 117:557.
2. Okano, Y. 1996. Antinuclear antibody in systemic sclerosis (scleroderma). Rheum. Dis. Clin. N. Am. 22:709.
3. Steen, V. D., Powell, D. L. and Medsger, T. A. Jr 1988. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum. 31:196.
4. Kuwana, M., Kaburaki, J., Okano, Y., Tojo, T. and Homma, M. 1994. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum. 37:75.
5. LeRoy, E. C., Black, C., Fleischmajer, R. et al. 1988. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J. Rheumatol. 15:9202.
6. Gussin, H. A., Ignat, G. P., Varga, J. and Teodorescu, M. 2001. Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus. Arthritis Rheum. 44:376.
7. Hamidou, M. A., Audrain, M. A., Masseau, A., Agard, C. and Moreau, A. 2006. Anti-topoisomerase I antibodies in systemic lupus erythematosus as a marker of severe nephritis. Clin. Rheumatol. 25:542.
8. Redinbo, M. R., Stewart, L., Kuhn, P., Champoux, J. J. and Hol, W. G. J. 1998. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science 279:1504.
9. D'Arpa, P., White-Cooper, H., Cleveland, D. W., Rothfield, N. F. and Earnshaw, W. C. 1990. Use of molecular cloning methods to map the distribution of epitopes on topoisomerase I (Scl-70) recognized by sera of scleroderma patients. Arthritis Rheum. 33:1501.
10. Verheijen, R., Van Den Hoogen, F., Beijer, R. et al. 1990. A recombinant topoisomerase I used for autoantibody detection in sera from patients with systemic sclerosis. Clin. Exp. Immunol. 80:38.
11. Piccinini, G., Cardellini, E., Reimer, G., Arnett, F. C. and Durban, E. 1991. An antigenic region of topoisomerase I in DNA polymerase chain reaction-generated fragments recognized by autoantibodies of scleroderma patients. Mol. Immunol. 28:333.
12. Cram, D. S., Fisicaro, N., McNeilage, L. J., Coppel, R. L. and Harrison, L. C. 1993. Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins. J. Immunol. 151:6872.
13. Kuwana, M., Kaburaki, J., Mimori, T., Tojo, T. and Homma, M. 1993. Autoantigenic epitopes on DNA topoisomerase I: Clinical and immunogenetic associations in systemic sclerosis. Arthritis Rheum. 36:1406.
14. Seelig, H. P., Schroter, H., Ehrfeld, H. and Renz, M. 1993. Autoantibodies against topoisomerase I detected with the natural enzyme and overlapping recombinant peptides. J. Immunol. Methods. 165:241.
15. Hu, P. Q., Fertig, N., Medsger, T. A. Jr and Wright, T. M. 2004. Molecular recognition patterns of serum anti-DNA topoisomerase I antibody in systemic sclerosis. J. Immunol. 173:2834.
16. Kuwana, M., Kaburaki, J., Mimori, T., Kawakami, Y. and Tojo, T. 2000. Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis. Arthritis Rheum. 43:1074.
17. Henry, P. A., Atamas, S. P., Yurovsky, V. V., Luzina, I., Wigley, F. M. and White, B. 2000. Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma. Arthritis Rheum. 43:2733.
18. Czirják, L., Kumánovics, G., Varjú, C. et al. 2008. Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann. Rheum. Dis. 67:59.
19. Ansuini, H., Cicchini, C., Nicosia, A., Tripodi, M., Cortese, R. and Luzzago, A. 2002. Biotin-tagged cDNA expression libraries displayed on lambda phage: A new tool for the selection of natural protein ligands. Nucleic Acids Res. 30:78.
20. Czömpöly, T., Olasz, K., Simon, D. et al. 2006. A possible new bridge between innate and adaptive immunity: Are the anti-mitochondrial citrate synthase autoantibodies components of the natural antibody network? Mol. Immunol. 43:1761.
21. Santini, C., Brennan, D., Mennuni, C. et al. 1998. Efficient display of an HCV cDNA expression library as C-terminal fusion to the capsid protein D of bacteriophage lambda. J. Mol. Biol. 282:125.
22. Rizou, C., Ioannidis, J. P., Panou-Pomonis, E. et al. 2000. B-cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis. Am. J. Respir. Cell Mol. Biol. 22:344.
23. Meesters, T. M., Hoet, M., van den Hoogen, F. H., Verheijen, R., Habets, W. J. and Van Venrooij, W. J. 1992. Analysis of an immunodominant epitope of topoisomerase I in patients with systemic sclerosis. Mol. Biol. Rep. 16:117.
24. Kato, T., Yamamoto, K., Takeuchi, H. et al. 1993. Identification of a universal B cell epitope on DNA topoisomerase I, an autoantigen associated with scleroderma. Arthritis Rheum. 36:1580.
25. Kuwana, M., Kaburaki, J., Medsger, T. A. Jr and Wright, T. M. 1999. An immunodominant epitope on DNA topoisomerase I is conformational in nature: Heterogeneity in its recognition by systemic sclerosis sera. Arthritis Rheum. 42:1179.
26. Casciola-Rosen, L., Andrade, F., Ulanet, D., Wong, W. B. and Rosen, A. 1999. Cleavage by granzyme B is strongly predictive of autoantigen status: Implications for initiation of autoimmunity. J. Exp. Med. 190:815.
27. Algiman, M., Dietrich, G., Nydegger, U., Boieldieu, D., Sultan, Y. and Kazatchkine, M. D. 1992. Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals. Proc. Natl Acad. Sci. USA 89:3795.
28. Bouanani, M., Piechaczyk, M., Pau, B. and Bastide, M. 1989. Significance of the recognition of certain antigenic regions on the thyroglobulin molecule by natural autoantibodies from healthy subjects. J. Immunol. 143:1129.
29. Sabbaga, J., Pankewycz, O. G., Lufft, V., Schwartz, R. S. and Madaio, M. P. 1990. Cross-reactivity distinguishes serum and nephritogenic anti-DNA antibodies in human lupus from their natural counterparts in normal serum. J. Autoimmun. 3:215.
30. Ronda, N., Haury, M., Nobrega, A., Kaveri, S. V., Coutinho, A. and Kazatchkine, M. D. 1994. Analysis of natural and disease-associated autoantibody repertoires: Anti-endothelial cell IgG autoantibody activity in the serum of healthy individuals and patients with systemic lupus erythematosus. Int. Immunol. 6:1651.